ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 330500 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 330500; 2) Community: the network communities that were significantly associated with the response to NSC 330500; 3) Molecule: the relationships between components within communities and NSC 330500; 4) MDR: the compounds that were significantly associated with the NSC 330500.

NSC Compound Enrichment Correlation
NSC 302289 BOHLMANN K2631 0.0376362543535815 0.40732907
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.0376362543535815 0.23963005
NSC 3091 Ammonium, [.alpha.-[p-(dimethylamino)phenyl]-.alpha.-[4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]-p-tolyl]ethyldimethyl-, bromide, chloride (8CI) 0.0376362543535815 0.47253089
NSC 328403 Acetamide, N-(4-formyl-5,6,7,9-tetrahydro-1,2,3,10- tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0376362543535815 0.59894889
NSC 174030 Null 0.0382675857669585 0.439079
NSC 174121 Methotrexate Derivative 0.0382675857669585 0.29601558
NSC 194350 Acridine Orange 0.0382675857669585 0.3293501
NSC 209835 [11]Cytochalasa-6(12),13,19-triene-1,17-dione, 21-(acetyloxy)-7,18-dihydroxy-16,18-dimethyl-10-phenyl-, (7S,13E,16S,18R,19E,21R)- (9CI) 0.0382675857669585 -0.12716736
NSC 271674 Carboxyphthalatoplatinum 0.0382675857669585 0.41792691
NSC 30637 Null 0.0382675857669585 0.43719943
Total:121  Current:101    [First] [Prev] [Next] [Last]